Biosimilars ‘making progress in the UK’
However, there still remain challenges for biosimilar companies trying to gain a foothold in the market, with reticence on the part of health trusts and clinicians taking time to break down.
The UK is an...
The benefits of government apprenticeship reforms to employers
Apprenticeships offer employers large and small a fantastic opportunity to get the skilled workforce they need to grow their business.
There are hundreds of thousands of employers up and down the country that are already...
Characterization of CRISPR/Cas9introduced Mutations using the Guide-it™ Indel Identification Kit
Streamlined method for characterizing the variety of indels introduced by genome editing technologies: Ideal foridentifying indels introduced by CRISPR/Cas9 genome editing in a cell population
A complete kit containing all of the components needed...
Companies announce new developments
An example of the new approach is seen in the way that several companies have been working to accurately and speedily diagnose zika virus.
In March, the US Food and Drug Administration gave authorisation to...
Genome-editing tools offer Pharmaceutical Companies new opportunities for drug discovery and development
Advances in genome editing technologies will beanother powerful tool available to scientists inJanssen R&D in their efforts to discover and develop safeand effective medicines.
By Inès Royaux, PhD
Senior Scientist at Janssen R&D
The ability to...
Exciting times in the field of asthma research
One of the areas in which truly exciting advances are being made is asthma, one of the commonest chronic diseases on the planet.
Professor Stephen Holgate, CBE, Chair of the Research Committee of the British...
Fledgling printing technology offers hope
One of the big medical changes ahead could relate to the production of tissue for implants, combining 3-D printing technology and bioscience.
Among those leading the way are scientists at the University of Bristol who...
A new way to manufacture small batches of biopharmaceuticals on demand
Biopharmaceuticals, a class of drugs comprising proteins such as antibodies and hormones, represent a fast-growing sector of the pharmaceutical industry. They’re increasingly important for “precision medicine” — drugs tailored toward the genetic or molecular...
But what of the future?
So nanotechnology is already producing developments but what is its potential? Well, the opportunities are huge and the work already under way could just be the start.
For example, the science could greatly speed up...
Discovery helps fight against drug-resistant Tuberculosis
A team of scientists have identified a naturally occurring antibiotic that may help in the fight against drug-resistant Tuberculosis.
Each year, approximately 10 million people fall ill with Tuberculosis (TB) and around 1.7 million die...
Trade Secrets – current and future protection
A trade secret is a piece of knowledge that gives you a competitive advantage over others in the field.
It must not be widely known, the owner must have taken deliberate steps to keep it...
Advances in analytical characterisation of biosimilars
The substantial improvement in the power of analyticalmethods to compare different versions of a givenprotein molecule should be taken into account whenconsidering the need for clinical studies for designation ofbiosimilarity. Arguably, demonstration of comparative...
Europe is “failing” to deal with chronic digestive disease burden
Europe is currently failing to manage the increasing burden inflicted by chronic digestive diseases, according to leading digestive health experts.
A report, published today during the launch of MEP Digestive Health Group, reveals alarming issues,...
Three-parent baby technology clears final hurdle
When science is at its best, it pushes the boundaries of what is possible and makes us think about the big questions. Even if the issues it raises are deeply uncomfortable.
That has certainly been...
Top tips to safeguard your medtech in a competitive industry
Medical technology is one of the fastest growing, and most competitive, industries in the world.
With a thriving ecosystem of over 3,700 companies, 115,000 skilled workers, and a turnover of over £21 billon, the UK’s...
Global community will assess environmental impact of clinical trials
The collaborative initiative will publish a publicly available methodology for calculating and comparing the carbon footprint of centralised and decentralised clinical trials.
A global, not-for-profit alliance that advocates for greater collaboration in life sciences R&D,...